Monopar Therapeutics Ownership | Who Owns Monopar Therapeutics?

Monopar Therapeutics Ownership Summary

Monopar Therapeutics is owned by 8.15% institutional investors, 23.23% insiders, and 68.62% retail investors. Janus henderson group is the largest institutional shareholder, holding 19.69% of MNPR shares. Polar Capital Biotech S Inc is the top mutual fund, with 3.20% of its assets in Monopar Therapeutics shares.

MNPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Monopar Therapeutics	8.15%	23.23%	68.62%
Sector	Healthcare Stocks	35.49%	11.78%	52.72%
Industry	Biotech Stocks	34.84%	11.71%	53.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	1.32M	19.69%	$72.06M
Ra capital management	667.21K	9.97%	$36.56M
Saturn v capital management	345.63K	5.16%	$18.94M
Deerfield management company, l.p. (series c)	323.75K	4.84%	$17.74M
Blackrock funding, inc. /de	316.57K	4.73%	$17.34M
Adage capital partners gp	309.19K	4.62%	$16.94M
Vanguard group	293.82K	4.12%	$19.19M
Siren	270.12K	4.04%	$14.80M
Polar capital	226.53K	3.38%	$12.41M
Wellington management group llp	174.34K	2.61%	$9.55M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Saturn v capital management	345.63K	3.43%	$18.94M
Ally bridge group (ny)	64.45K	3.21%	$5.26M
Sio capital management	173.51K	1.36%	$9.51M
Adar1 capital management	130.00K	1.00%	$10.62M
Vivo capital	90.50K	0.41%	$4.96M
Siren	270.12K	0.41%	$14.80M
Ra capital management	667.21K	0.39%	$36.56M
Silverarc capital management	43.49K	0.24%	$2.38M
Deerfield management company, l.p. (series c)	323.75K	0.21%	$17.74M
Tcg crossover management	132.10K	0.21%	$7.24M

Top Buyers

Holder	Shares	% Assets	Change
Sio capital management	173.51K	1.36%	173.51K
Deerfield management company, l.p. (series c)	323.75K	0.21%	153.19K
Polar capital	226.53K	0.04%	120.78K
Balyasny asset management	136.44K	0.01%	104.54K
Vanguard group	293.82K	0.00%	85.60K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	309.19K	0.03%	-330.27K
Point72 asset management	-	-	-104.02K
Deep track capital, lp	-	-	-95.41K
Affinity asset advisors	-	-	-79.48K
Wellington management group llp	174.34K	0.00%	-51.73K

New Positions

Holder	Shares	% Assets	Change	Value
Sio capital management	173.51K	1.36%	173.51K	$9.51M
Vestal point capital, lp	65.42K	0.10%	65.42K	$3.58M
Walleye capital	63.12K	0.01%	63.12K	$3.46M
Silverarc capital management	43.49K	0.24%	43.49K	$2.38M
Vanguard fiduciary trust	28.45K	0.00%	28.45K	$1.56M

Sold Out

Holder	Change
Srs capital advisors	-14.00
Federation des caisses desjardins du quebec	-16.00
Amalgamated bank	-144.00
Point72 (difc)	-196.00
Raymond james financial	-431.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	23	-68.06%	545,109	-90.13%	8	0.14%	13	-76.36%	5	-44.44%
Dec 31, 2025	41	-25.45%	1,444,487	-66.69%	20	0.53%	30	-9.09%	4	-73.33%
Sep 30, 2025	51	18.60%	4,170,111	31.28%	59	2.89%	31	-8.82%	15	275.00%
Jun 30, 2025	43	26.47%	3,176,497	10.06%	45	266.08%	34	47.83%	4	-20.00%
Mar 31, 2025	34	88.89%	2,886,019	11.94%	4	8.93%	23	53.33%	5	400.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Polar Capital Biotech S Inc	214.24K	3.20%	14.24K
Vanguard Total Stock Mkt Idx Inv	167.99K	2.51%	-
Janus Henderson Hrzn Biotec E2 USD	129.27K	1.93%	-
iShares Russell 2000 ETF	105.06K	1.57%	893.00
Fidelity Small Cap Index	44.91K	0.67%	509.00
Vanguard Institutional Extnd Mkt Idx Tr	44.47K	0.66%	1.78K
iShares Russell 2000 Growth ETF	35.30K	0.53%	90.00
Russell 2000 Equity Index Fund B	30.48K	0.46%	4.97K
State St Russell Sm/Mid Cp® Indx SL Cl I	28.16K	0.42%	-
BNY Mellon Sm/Md Cp Gr I	26.21K	0.39%	-321.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 26, 2025	Vu Quan Anh	Chief Financial Officer	Buy	$104.92K
Dec 18, 2025	KLAUSNER ARTHUR J	-	Sell	$312.50K
Dec 18, 2025	KLAUSNER ARTHUR J	-	Sell	$31.39K
Sep 24, 2025	Tactic Pharma LLC	-	Sell	$35.00M
Jul 14, 2025	Tsuchimoto Kim R	-	Sell	$356.17K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	1	2
2025 Q3	-	4
2025 Q2	-	1
2025 Q1	-	-

MNPR Ownership FAQ

Who Owns Monopar Therapeutics?

Monopar Therapeutics shareholders are primarily institutional investors at 8.15%, followed by 23.23% insiders and 68.62% retail investors. The average institutional ownership in Monopar Therapeutics's industry, Biotech Stocks , is 34.84%, which Monopar Therapeutics falls below.

Who owns the most shares of Monopar Therapeutics?

Monopar Therapeutics’s largest shareholders are Janus henderson group (1.32M shares, 19.69%), Ra capital management (667.21K shares, 9.97%), and Saturn v capital management (345.63K shares, 5.16%). Together, they hold 34.82% of Monopar Therapeutics’s total shares outstanding.

Does Blackrock own Monopar Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Monopar Therapeutics.

Who is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested?

Saturn v capital management is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.43% of its assets in 345.63K Monopar Therapeutics shares, valued at 18.94M$.

Who is the top mutual fund holder of Monopar Therapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Monopar Therapeutics shares, with 3.20% of its total shares outstanding invested in 214.24K Monopar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools